Abstract：Objective: To analyze the relationship between serum neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), neutrophil-monocyte ratio (NMR), and prognosis in patients with esophageal cancer. Methods: A total of 116 patients with esophageal cancer undergoing radical resection in the hospital were enrolled as an observation group between January 2017 and January 2021, while other 116 healthy controls during the same period were enrolled as the control group. The levels of white blood cell count (WBC), neutrophils, lymphocytes, and monocytes were detected by a hematology analyzer. NLR, LMR, and NMR were analyzed. The 12-month prognosis of patients with esophageal cancer was statistically analyzed. The patients with recurrence increased staging, other organ metastasis, and death was enrolled as a poor prognosis group, while the remaining were enrolled as a good prognosis group. The predictive value of NLR, LMR, and NMR for the prognosis of patients with esophageal cancer was analyzed by receiver operating characteristic (ROC) curves. Results: There was no significant difference in levels of WBC, neutrophils, and lymphocytes between the two groups (P>0.05). The level of monocytes in the observation group was lower than that in the control group (P<0.05). There was no significant difference in NLR between the two groups (P>0.05). LMR in the observation group was significantly lower than that in the control group, while NMR was significantly higher than that in the control group (P<0.05). There was no significant difference in NLR between the stage I+II group and the stage III group. LMR in the stage I+II group was higher than that in the stage III group, while NMR was lower than that in the stage III group (P<0.05). Of the 116 patients with esophageal cancer, there were 32 cases (27.85%) with poor prognoses. The levels of serum NLR and NMR in the poor prognosis group were significantly higher than those in the good prognosis group, while LMR was significantly lower than that in the good prognosis group (P<0.05). AUC values of serum NLR, LMR, and NMR for predicting the prognosis of esophageal cancer were 0.766, 0.799, and 0.708, respectively (P<0.05). Taking 2.670, 4.379, and 15.896 as the cut-off values of NLR, LMR, and NMR, the sensitivity and specificity of combined detection (parallel mode) for predicting prognosis were 93.75% and 64.29%, respectively. The sensitivity of combined detection was higher than that of a single index. Conclusion: Serum NLR, LMR, and NMR are related to the prognosis of patients with esophageal cancer. The combined detection of serum NLR, LMR, and NMR levels have important clinical value in diagnosing esophageal cancer and predicting 1-year prognosis.
胡俊泽, 谢权, 马建伟, 申彬, 关丽. 食管癌患者血清NLR LMR NMR与预后的关系研究[J]. 河北医学, 2023, 29(2): 254-259.
HU Junze, XIE Quan, MA Jianwei, et al. Study on the Relationship between Serum NLR LMR NMR and Prognosis of Esophageal Cancer Patients. HeBei Med, 2023, 29(2): 254-259.
[1] 李学明,廖萌,周鹏,等.CT冠状动脉血管成像在食管癌及肺癌患者术前检查中的应用价值[J].川北医学院学报,2020,35(4):625-628. [2] Watanabe M,Otake R,Kozuki R,et al.Recent progress in multidisciplinary treatment for patients with esophageal cancer[J].Surg Today,2020,50(1):12-20. [3] Li W,Ren X,Zhang L.Clinical efficacy of atorvastatin calcium combined with aspirin in patients with acute ischemic stroke and effect on neutrophils,lymphocytes and IL-33[J].Exp Ther Med,2020,20(2):1277-1284. [4] 刘军玲,周革,郭宏斌.IL-6联合NLR对三阴性乳腺癌术后患者预后的预测价值[J].中国医药导报,2020,(8):113-116. [5] Mandaliya H,Jones M,Oldmeadow C,et al.Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC):neutrophil to lymphocyte ratio (NLR),lymphocyte to monocyte ratio (LMR),platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)[J].Transl Lung Cancer Res,2019,8(6):886-894. [6] 中国抗癌协会食管癌专业委员会编.食管癌规范化诊治指南[M].中国协和医科大学出版社,2013. [7] 赵继波,李媛莉,夏登云,等.LCR、PVI与IVCrvi目标导向液体治疗对单肺通气老年全腔镜食管癌根治术患者血流动力学的影响[J].中南医学科学杂志,2022,50(4):543-546. [8] 唐忠,陈勇,李峰,等.微创与开放手术治疗食管癌的临床对照研究[J].成都医学院学报,2020,15(1):99-101. [9] 陈双凤,吉亚南.温阳活血方对卵巢癌患者免疫指标及炎性因子的影响[J].陕西中医,2021,42(10):1371-1374. [10] 李征燃,李红卫,张霞琴,等.根治性放疗前外周血中性粒细胞与淋巴细胞比值对食管鳞状细胞癌患者总生存的影响[J].肿瘤研究与临床,2021,33(11):848-852. [11] 冯薇臻,欧阳楚桐,余思思,等.中性粒细胞/淋巴细胞比值与淋巴细胞/单核细胞比值对外周T细胞淋巴瘤患者的预后影响分析[J].国际输血及血液学杂志,2020,43(3):241-250. [12] Singh S,Singh J,Ganguly R,et al.Diagnostic efficacy of neutrophil to lymphocyte ratio (NLR) in oral potentially malignant disorders and oral cancer[J].Indian Pathol Microbiol,2021,64(2):243-249. [13] 姚菲菲,郭锋,赵大海.化疗前ALI、NLR、LMR水平对野生型晚期非小细胞肺癌患者预后的影响[J].临床肺科杂志,2020,25(8):1212-1217 [14] 赵雅文,董頔,薛茜文,等.术前外周血中NLR、PLR、LMR与早期宫颈癌患者预后的相关性研究[J].新疆医科大学学报,2020,43(8):997-1003. [15] 王孟君,李国鑫,张娟.宫颈癌根治术前患者的NLR、PLR、LMR、RDW水平变化及临床意义[J].海南医学,2021,32(22):2884-2886.
2023, Vol. 29 
冀公网安备13080202000677号